Pathology and Diagnosis of Neuroendocrine Tumors: Lung Neuroendocrine

Thoracic Surgery Clinics

Volumn 24, Issue 3, 2014, Pages 257-266

  Travis, William D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Atypical carcinoid; Carcinoid; Large cell neuroendocrine carcinoma; Lung; Neuroendocrine; Neuroendocrine cell hyperplasia; Small cell carcinoma; Typical carcinoid

Indexed keywords

ATYPICAL CARCINOID; CARCINOID; COPY NUMBER VARIATION; DIFFERENTIAL DIAGNOSIS; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; ELECTRON MICROSCOPY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG CANCER; LUNG NODULE; MITOSIS RATE; NEUROENDOCRINE TUMOR; NON SMALL CELL LUNG CANCER; OPEN LUNG BIOPSY; PRIORITY JOURNAL; PULMONARY NEUROENDOCRINE TUMOR; REVIEW; SMALL CELL LUNG CANCER; TUMOR CLASSIFICATION; TUMOR NECROSIS; TUMORLET; TYPICAL CARCINOID; LUNG; LUNG TUMOR; NEUROENDOCRINE; NEUROENDOCRINE CELL HYPERPLASIA; PATHOLOGY; SMALL CELL CARCINOMA;

ATYPICAL CARCINOID; CARCINOID; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG; NEUROENDOCRINE; NEUROENDOCRINE CELL HYPERPLASIA; SMALL CELL CARCINOMA; TYPICAL CARCINOID;

CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS;

EID: 84907055417     PISSN: None     EISSN: 15585069     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2014.04.001     Document Type: Review

References (43)

1. Travis W.D. Advances in neuroendocrine lung tumors. Ann Oncol 2010, 21(Suppl 7):vii65-vii71.
2. Travis W.D., Brambilla E., Miller-Hermelink H.K., et al. Pathology and genetics: tumours of the lung, pleura, thymus and heart 2004, IARC, Lyon (France).
3. Surveillance Epidemiology, and End Results (SEER) Program. Lung cancer histologically confirmed SEER 18 registries research data plus Hurricane Katrina impacted Louisiana cases 1973-2010, November 2012; Total US County Attributes. April 2013 edition. 2013. Available at: . National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. http://www.seer.cancer.gov.
4. Chen L.C., Travis W.D., Krug L.M. Pulmonary neuroendocrine tumors: what (little) do we know?. J Natl Compr Canc Netw 2006, 4:623-630.
5. Clinical Lung Cancer Genome Project (CLCGP), Network Genomic Medicine (NGM) A genomics-based classification of human lung tumors. Sci Transl Med 2013, 5:209ra153.
6. Fernandez-Cuesta L., Peifer M., Lu X., et al. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nature communications 2014, 5:3518.
7. Onuki N., Wistuba I.I., Travis W.D., et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999, 85:600-607.
8. Hiroshima K., Iyoda A., Shibuya K., et al. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma. Cancer 2004, 100:1190-1198.
9. Iyoda A., Hiroshima K., Moriya Y., et al. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity. Ann Thorac Surg 2004, 77:1891-1895.
10. Przygodzki R.M., Finkelstein S.D., Langer J.C., et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 1996, 148:1531-1541.
11. Siegel R., Ma J., Zou Z., et al. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
12. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
13. Nicholson S.A., Beasley M.B., Brambilla E., et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002, 26:1184-1197.
14. Kreyberg L. Histological lung cancer types. Acta Pathol Microbiol Scand Suppl 1962, 157(Suppl):1-92.
15. World Health Organization. Histologic typing of lung tumours 1981, World Health Organization, Geneva (Switzerland). 2nd edition.
16. Hirsch F.R., Matthews M.J., Aisner S., et al. Histopathologic classification of small cell lung cancer. Changing concepts and terminology. Cancer 1988, 62:973-977.
17. Fraire A.E., Johnson E.H., Yesner R., et al. Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol 1992, 23:520-528.
18. Travis W.D., Colby T.V., Corrin B., et al. Histological typing of lung and pleural tumors 1999, In collaboration with Sobin LH and pathologists from 14 countries, Springer, Berlin.
19. Travis W.D. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol 2012, 25(Suppl 1):S18-S30.
20. Vollmer R.T. The effect of cell size on the pathologic diagnosis of small and large cell carcinomas of the lung. Cancer 1982, 50:1380-1383.
21. Folpe A.L., Gown A.M., Lamps L.W., et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999, 12:5-8.
22. Agoff S.N., Lamps L.W., Philip A.T., et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000, 13:238-242.
23. Sturm N., Lantuejoul S., Laverriere M.H., et al. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 2001, 32:918-925.
24. Pelosi G., Rindi G., Travis W.D., et al. Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol 2014, 9:273-284.
25. Pelosi G., Rodriguez J., Viale G., et al. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 2005, 29:179-187.
26. Travis W.D., Gal A.A., Colby T.V., et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998, 29:272-279.
27. Roggli V.L., Vollmer R.T., Greenberg S.D., et al. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985, 16:569-579.
28. Shiao T.H., Chang Y.L., Yu C.J., et al. Epidermal growth factor receptor mutations in small cell lung cancer: a brief report. J Thorac Oncol 2011, 6:195-198.
29. Travis W.D., Linnoila R.I., Tsokos M.G., et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15:529-553.
30. Travis W.D. Neuroendocrine lung tumors. Path Case Reviews 2006, 11:235-242.
31. Iyoda A., Hiroshima K., Baba M., et al. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors. Ann Thorac Surg 2002, 73:1049-1054.
32. Travis W.D., Rush W., Flieder D.B., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998, 22:934-944.
33. Iyoda A., Hiroshima K., Toyozaki T., et al. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 2001, 91:1992-2000.
34. Oshiro Y., Kusumoto M., Matsuno Y., et al. CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR Am J Roentgenol 2004, 182:87-91.
35. Hiroshima K., Abe S., Ebihara Y., et al. Cytological characteristics of pulmonary large cell neuroendocrine carcinoma. Lung Cancer 2005, 48:331-337.
36. Zacharias J., Nicholson A.G., Ladas G.P., et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 2003, 75:348-352.
37. Ionescu D.N., Treaba D., Gilks C.B., et al. Nonsmall cell lung carcinoma with neuroendocrine differentiation - an entity of no clinical or prognostic significance. Am J Surg Pathol 2007, 31:26-32.
38. Gupta R., Dastane A., McKenna R.J., et al. What can we learn from the errors in the frozen section diagnosis of pulmonary carcinoid tumors? An evidence-based approach. Hum Pathol 2009, 40:1-9.
39. Du E.Z., Goldstraw P., Zacharias J., et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 2004, 35:825-831.
40. Rindi G., Klersy C., Inzani F., et al. Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 2014, 21:1-16.
41. Nassar A.A., Jaroszewski D.E., Helmers R.A., et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Am J Respir Crit Care Med 2011, 184:8-16.
42. Davies S.J., Gosney J.R., Hansell D.M., et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007, 62:248-252.
43. World Health Organization Histological typing of lung tumours 1967, World Health Organization, Geneva (Switzerland).